hVIVO (HVO) is a specialty biopharma discovery and clinical testing company that is pioneering a human disease technology platform that models respiratory (airway) and infectious diseases. After raising £20m at 225p this could be the last year of losses…….

The Interims to June reported the strongest sales pipeline for several years and translation into active negotiations, with top-tier pharmaceutical companies, should lead to long term contracts. Based in the UK, more than 50 clinical studies have conducted with over 2,500 volunteers inoculated. hVIVO is currently presenting at the Influe...